Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $212.6 million.

  • Strata Critical Medical's Non-Current Assets rose 9120.92% to $212.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $508.2 million, marking a year-over-year increase of 3163.74%. This contributed to the annual value of $95.9 million for FY2024, which is 818.25% up from last year.
  • Strata Critical Medical's Non-Current Assets amounted to $212.6 million in Q3 2025, which was up 9120.92% from $101.4 million recorded in Q2 2025.
  • Strata Critical Medical's Non-Current Assets' 5-year high stood at $278.1 million during Q1 2021, with a 5-year trough of $3.4 million in Q2 2021.
  • Moreover, its 5-year median value for Non-Current Assets was $98.2 million (2025), whereas its average is $98.7 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 9876.64% in 2021, then surged by 124391.81% in 2022.
  • Over the past 5 years, Strata Critical Medical's Non-Current Assets (Quarter) stood at $40.9 million in 2021, then soared by 161.12% to $106.9 million in 2022, then fell by 17.05% to $88.7 million in 2023, then grew by 8.18% to $95.9 million in 2024, then soared by 121.61% to $212.6 million in 2025.
  • Its last three reported values are $212.6 million in Q3 2025, $101.4 million for Q2 2025, and $98.2 million during Q1 2025.